Addictiveness: Is Carisoprodol Addictive? Call 703-844-0184 for addiction help : Yes, carisoprodol can cause dependence and addiction. When first manufactured, carisoprodol was not a controlled substance. But after becoming an extremely popular and frequently prescribed muscle relaxant, users started to abuse it more and more. This was one of the main reasons why on December 12, 2011 the Drug Enforcement Administration (DEA) classified carisoprodol (known by its brand name, Soma) a schedule IV, controlled substance. When taken, the body metabolizes carisoprodol into a drug called meprobamate, which is itself a minor tranquilizer. Meprobamate is classified by the DEA as a Schedule IV drug bec
Opioid Overdose risks and Buprenorphine| suboxone treatment in the Emergency Department | 703-844-01
Addiction Domain Blog Opioid Deaths in The U.S.| trends and Risk Factors 2003-2014 Rates of opioid overdose hospitalizations increased between 2003 and 2014 in the United States, primarily for Caucasians in the South; factors associated with a higher mortality from opioid overdose also include younger age and male gender, according to a study to be presented at the 2018 World Congress on Pain, held September 12-16 in Boston, Massachusetts. Considering the prevalence of opioid overdose and poisoning in the United States, and the accompanying high rates of addiction and death, researchers analyzed Nationwide Inpatient Sample data on opioid overdose from 2003 to 2014 to identify predictors of m
Kratom is an herbal supplement that shares structural similarities with opioid analgesics Opioid-like dependence due to chronic kratom use can be successfully treated with buprenorphine, according to a recent case report published in the Journal of Addiction Medicine. Kratom, an herbal supplement that shares structural similarities with opioid analgesics, has recently grown in popularity as an unapproved opioid replacement therapy. The drug is easily obtained via the Internet (as it does not require a prescription), but oftentimes contains higher than typical doses and may be mixed with adulterants, increasing the risk of toxicity. In their article, the authors report on two patients who use
Treatment Rescue: Addressing Chronic Relapse August 21, 2017 From a Stages of Change perspective, the client clearly acknowledges that he is an addict and that his drug use is a problem. However, we were able to identify some problems in his preparation and action stage efforts. When he completes treatment, he agrees to discharge planning; he signs off on “the plan.” But when he stalls out during the action stage, we were able to see how his commitment to follow the plan has usually been a case of agreeing to do something he either 1) didn't intend to follow, or 2) didn't know what it really meant. For example: a. He never followed through with the “peer-based support” part of the plan. Thi
